Company: SLDE
Filing Date: 2025-03-10
Form Type: DRS/A
Source: 0000950123-25-003025
Chunk: 172

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-03-10
Form: DRS/A
Chunk 172
---
exercisable shares underlying this option become vested and exercisable in equal                                                                                          
 monthly installments of 6,250 shares over a period of 9 months through September 13, 2025, subject to the named executive officer’s continued employment or service through each monthly vesting date. |

| (3) | The remaining unvested and exercisable shares underlying this option become vested and exercisable if a                                                       
 positive EBITDA for calendar 2025 is attained by the Company, subject to the named executive officer’s continued employment or service at such vesting event. |

| (4) | 50,000 shares underlying this option become vested and exercisable upon each of the following: (i) the                                                                                                                                    
 first occurrence of the launch of the Company in a new state; and (ii) positive EBITDA for calendar 2025 is attained by the Company, subject to the named executive officer’s continued employment or service at each such vesting event. |

| (5) | The shares underlying this option become vested and exercisable as to 5,000 shares subject to the option on                   
 March 1 of 2025 and 2026, subject to the named executive officer’s continued employment or service through each vesting date. |

117

| (6) | The shares underlying this option become vested and exercisable as to 10,000 shares subject to the option on             
 September 1 of 2025, subject to the named executive officer’s continued employment or service through each vesting date. |

| (7) | The shares underlying this option become vested and exercisable as to 25,000 shares subject to the option on                     
 January 31 of 2025 and 2026, subject to the named executive officer’s continued employment or service through each vesting date. |

| (8) | The remaining unvested and unexercisable shares underlying this option become vested and exercisable in equal                                                                                          
 monthly installments of 1,250 shares over a period of 9 months through September 13, 2025, subject to the named executive officer’s continued employment or service through each monthly vesting date. |

| (9) | 50,000 shares underlying this option become vested and exercisable upon each of the following: (i) the                                                                                                   
 occurrence of the launch of the Company in a new state, and (ii) positive EBITDA for calendar 2025, subject to the named executive officer’s continued employment or service